Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,887
Sort by:
Global Suppliers of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Analyzers and Reagents
US$ 4,750.00
... .com provides analyses of 100 major and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation ... report presents strategic profiles of 100 major and emerging suppliers of diagnostic products, including their sales, product portfolios ...
June 2019
200 pages
Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers
US$ 3,850.00
This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and ...
June 2019
154 pages
2019 US Drugs of Abuse Testing Analyzers and Reagents: Supplier Sales and Shares, Sales Segment Forecasts--Hospitals, Commercial Laboratories, POC Locations--Competitive Landscape, Emerging Technologies, Instrumentation Review
US$ 4,500.00
... page report from VPGMarketResearch provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales ... PCP), Propoxyphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...
June 2019
278 pages
2019 POC Hematology and Flow Cytometry Testing Market: Reagent and Instrument Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers
US$ 7,500.00
VPGMarketResearch’s new report provides comprehensive analysis of the POC hematology and flow cytometry markets, including their dynamics, size, growth ... closer to the patient. Market Segmentation Review of POC hematology and flow cytometry market segments, including their dynamics, trends, structure ...
June 2019
279 pages
2019 POC Coagulation Testing Market: Reagent and Instrument Supplier Shares, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers
US$ 7,500.00
VPGMarketResearch’s new report provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, technological trends, ...
June 2019
450 pages
U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets, 2019-2023: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
US$ 1,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
June 2019
408 pages
Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Testing, 2019-2023: US, Europe, Japan--Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
US$ 8,750.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
June 2019
570 pages
Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
US$ 4,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
June 2019
495 pages
France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets, 2019-2023: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape
US$ 1,850.00
... diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the ... opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ...
June 2019
407 pages
